Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F Felizzi
Prm155 - Joint Modeling of Overall Survival and Progression Free Survival
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prm251 - Evaluating Budget Impact of Cures. Machine Learning Methods Shed Light on Who Can Be Cured in Metastatic Melanoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Multivariate Network Meta-Analysis of Progression Free Survival and Overall Survival
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prm122 - Bootstrapping Progression-Free Survival and Overall Survival to Capture Their Correlation in Probabilistic Sensitivity Analyses
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Relationship Between Progression-Free Survival and Overall Survival in Chronic Lymphocytic Leukemia: A Literature-Based Analysis
Current Oncology
Oncology
To Join or Not to Join? Analysis of Progression-Free and Overall Survival Using Multi-State Modeling
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Overall and Progression-Free Survival in Metastatic Melanoma: Analysis of a Single-Institution Database
Cancer Control
Medicine
Oncology
Hematology
Network Meta-Analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma
Oncology and Therapy
Oncology
Overall Survival and Progression-Free Survival With Endocrine Therapy for Hormone Receptor-Positive, HER2-negative Advanced Breast Cancer: Review
Therapeutic Advances in Medical Oncology
Oncology
Predictors of Progression-Free Survival and Overall Survival in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Single-Center Experience
World Journal of Oncology
Cancer Research
Oncology
Therapeutic Effect of Apatinib on Overall Survival Is Mediated by Prolonged Progression-Free Survival in Advanced Gastric Cancer Patients
Oncotarget
Oncology